2021, Number 2
<< Back Next >>
Revista del Hospital Psiquiátrico de La Habana 2021; 18 (2)
Neuropsychological evaluation of a case of Wernicke´s aphasia
Cortés CN, Seubert RAN
Language: Spanish
References: 20
Page:
PDF size: 390.48 Kb.
ABSTRACT
Introduction: This case illustrates a glioblastoma multiforme that generated aphasia. Although aphasia is usually a sequel of a cerebral vascular event, it has been reported to be present after a tumor lesion; which makes the present case valuable and exemplifies the importance of neuropsychology in oncologic disease.
Objective: To present a clinical case that illustrates how a tumor lesion can cause cognitive symptomatology.
Case presentation: After identifying an intra-axial tumor lesion in the left temporoinsular region by structural MRI, the patient underwent tumor biopsy and resection. A pre-surgical neuropsychological evaluation was requested. From the application of the Barcelona Brief Test, a fluent language with agrammatisms, phonological and literal paraphasias in spontaneous language, repetition and naming, phonological paragraphies, diminished informative content and difficulties in sentence comprehension were identified; suggesting Wernicke's aphasia. An anatomical correlation has been described between a lesion in the posterior superior temporal gyrus and Wernicke's aphasia, as observed in the case. Specifically, the patient presented with Wernicke's aphasia type I and II due to the anatomofunctional correlate and the presence of fluent speech, agrammatisms and paraphasias.
Conclusions: The patient's relatively small oncologic lesion generated a florid and sudden cognitive symptomatology. A neuropsychological evaluation identified the presence of Wernicke's aphasia.
REFERENCES
Olar A, Aldape KD. Using the molecular classification of glioblastoma to inform personalized treatment. J Pathol. 2014;232(2):165-77. PMID: 24114756
Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. Neuro Oncol. 2018;20(suppl_4):iv1-iv86. PMID: 30445539
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2): 97-109. PMID: 17618441
Engelhard HH, Villano JL, Porter KR, Stewart AK, Barua M, Barker FG, Newton HB. Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina. J Neurosurg Spine. 2010;13(1):67-77. PMID: 20594020
Rijnen SJM, Butterbrod E, Rutten GM, Sitskoorn MM, Gehring K. Presurgical Identification of Patients with Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up. Neurosurg. 2020;87(6):1119–29. PMID: 32470985
Le H, Lui MY. Aphasia. 2021. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 32644741
De Dios S, Durkin NM, Soble JR. Case of right hemispatial neglect and transcortical sensory aphasia following left occipitotemporoparietal glioblastoma resection. Appl Neuropsychol Adult. 2021;28(1):117-23. PMID: 30987454
Peña J. Programa Integrado de Exploración Neuropsicológica. España: Masson; 1986.
Asociación Médica Mundial (AMM). Declaración de Helsinki de la AMM. Principios éticos para las investigaciones médicas en seres humanos. JAMA.2017;310(20):2191-4. DOI: 10.1001/jama.2013.281053
Peña J. Normalidad, Semiología y Patología Neuropsicológicas. España: Masson; 1991.
Damasio A. Signs of Aphasia. En: Taylor M (ed.) Acquired Aphasia (3.er ed.). EUA, Nueva York: Academic Press; 1998. pp. 25-40.
Ardila A. Las afasias. Guadalajara: Universidad de Guadalajara; 2005.
Lebrun Y. Anosognosia in aphasics. Cortex. 1987;23(2):251-63. PMID: 2440639
Vendrell JM. Las afasias: semiología y tipos clínicos. Rev Neurol. 2001;32(10):980-6. PMID: 11424058
Damasio H. Neuroanatomical Correlates of the Aphasia. En: Taylor M (ed.) Acquired Aphasia (3.er ed.). EUA, Nueva York: Academic Press; 1998. pp. 43-70.
Solanki C, Sadana D, Arimappamagan A, Rao KVLN, Rajeswaran J, Subbakrishna DK, Santosh V, Pandey P.Impairments in Quality of Life and Cognitive Functions in Long-term Survivors of Glioblastoma. J Neurosci Rural Pract. 2017; 8(2):228-35. PMID: 28479798
Gately L, McLachlan SA, Dowling A, Philip J. Life beyond a diagnosis of glioblastoma: a systematic review of the literature. J Cancer Surviv. 2017; 11(4): 447–452. DOI: 10.1007/s11764-017-0602-7
Catt S, Chalmers A, Fallowfield L. Psychosocial and supportive-care needs in high-grade glioma. Lancet Oncol. 2008;9(9):884-91. PMID: 18760244
Malec J. Evaluación para planear la rehabilitación neuropsicológica. En: Moreno G (ed.) Rehabilitación neuropsicológica.Manual Internacional. México, CDMX: Manual Moderno; 2019. pp. 36-48.
Preusser M, de Ribaupierre S, Wöhrer A, Erridge SC, Hegi M, Weller M, et al. Current concepts and management of glioblastoma. Ann Neurol. 2011;70(1):9-21. DOI: 10.1002/ana.22425. PMID: 21786296